[Clinical study of antinib combined with radiotherapy in the treatment of third-line extensive small cell lung cancer].

Zong, Y F; Tan, Y; Baerxiaguli, Zhabihula; Wang, H F

Zong, Y F; Tan, Y; Baerxiaguli, Zhabihula; Wang, H F.

Afiliación

Zong YF; Department of Radiotherapy of the Chest and Abdomen, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi 830011, China.
Tan Y; Department of Radiotherapy of the Chest and Abdomen, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi 830011, China.
Baerxiaguli Z; Department of Radiotherapy of the Chest and Abdomen, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi 830011, China.
Wang HF; Department of Radiotherapy of the Chest and Abdomen, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi 830011, China.

Zhonghua Zhong Liu Za Zhi ; 45(10): 892-897, 2023 Oct 23.

Article en Zh | MEDLINE | ID: mdl-37875425

Asunto(s)

Neoplasias Pulmonares; Carcinoma Pulmonar de Células Pequeñas; Humanos; Carcinoma Pulmonar de Células Pequeñas/tratamiento farmacológico; Carcinoma Pulmonar de Células Pequeñas/radioterapia; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/radioterapia; Calidad de Vida; Resultado del Tratamiento; Supervivencia sin Progresión

Palabras clave

Anlotinib; Lung neoplasms; Radiotherapy; Safety; Small cell carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google